Economic evaluation of micafungin vs. Liposomal Amphotericin B (LAmB) for the treatment of candidaemia and Invasive Candidiasis (IC)
about
Micafungin: an evidence-based review of its place in therapyInfluence of the freeze-drying process on the physicochemical and biological properties of pre-heated amphotericin B micellar systemsPharmacoeconomic evaluation of micafungin versus caspofungin as definitive therapy for candidaemia and invasive candidiasis (IC) in Turkey.
P2860
Economic evaluation of micafungin vs. Liposomal Amphotericin B (LAmB) for the treatment of candidaemia and Invasive Candidiasis (IC)
description
scientific article published on 18 March 2013
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2013
@uk
name
Economic evaluation of micafun ...... and Invasive Candidiasis (IC)
@en
Economic evaluation of micafungin vs. Liposomal Amphotericin B
@nl
type
label
Economic evaluation of micafun ...... and Invasive Candidiasis (IC)
@en
Economic evaluation of micafungin vs. Liposomal Amphotericin B
@nl
prefLabel
Economic evaluation of micafun ...... and Invasive Candidiasis (IC)
@en
Economic evaluation of micafungin vs. Liposomal Amphotericin B
@nl
P2093
P2860
P50
P356
P1433
P1476
Economic evaluation of micafun ...... and invasive candidiasis (IC)
@en
P2093
Debbie Marriott
Kay Stewart
Orla Morrissey
Sharon C-A Chen
P2860
P304
P356
10.1111/MYC.12071
P577
2013-03-18T00:00:00Z